FDA limits use of risky Sanofi antibiotic Ketek
Mon, 12 Feb 2007 06:08 PM EST
... WASHINGTON (Reuters) - Sanofi-Aventis SA's antibiotic Ketek should no longer be used to treat sinusitis and bronchitis, U.S. officials warned on Monday, saying the controversial drug was too risky to treat those diseases. ...
Related Topics
- Telithromycin
- Antibiotics
- Hydrocortisone, Neomycin, and Polymyxin Otic
- Carcinogens
- Antibiotic Resistance
- Tacrolimus ointment
- Mammography
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Antibiotic-associated diarrhea
- Thalidomide
- Polymyxin B, Bacitracin, and Neomycin
- Cefuroxime
- Cephalexin
- Viral Infections
- Sulfamethoxazole and Trimethoprim
- Food Labeling
- Streptomycin
- Drug Safety
- Yohimbe

Not Signed In -


